TVRD Tvardi Therapeutics, Inc.
1.100USD+1.85%Mkt Cap: 14.67M $P/E: —1d ago
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap14.67M USD
Enterprise Value-1.21M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-18.21M USD
Revenue/Share—
Last Price1.100 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees12
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.48
PEG—
EV/EBITDA0.04
EV/Revenue—
P/S—
P/B0.70
EPS (TTM)-2.69
EPS (Forward)-2.24
52W Range
0.93000% of range43.65
52W High43.65 USD
52W Low0.9300 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-86.96%
ROA-56.79%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.50M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-110.80%
Net Debt-15.62M USD
Net Debt/EBITDA0.58
Balance Sheet
Debt/Equity0.01
Current Ratio1.87
Quick Ratio1.73
Book Value/Sh1.55 USD
Cash/Share1.18 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:3
Split DateApr 16, 2025
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)9.250 USD
Upside (mean)+740.9%
Target Range3.000 USD – 14.00 USD
3.000+740.9% to mean14.00
# Analysts8
Ownership
Shares Out.13.34M
Float9.63M
Insiders24.36%
Institutions17.33%
Short Interest
Short Ratio2.0d
Short % Float1.92%
Short % Out.1.92%
Shares Short255.53K
Short (prev mo.)173.31K
Technical
SMA 501.757 (-37.4%)
SMA 2003.062 (-64.1%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)211.99K
Avg Vol (10d)343.63K
Technical Indicators
RSI (14)29.3
MACD-0.2248
MACD Signal-0.2089
MACD Hist.-0.0159
BB Upper2.118 USD
BB Middle1.471 USD
BB Lower0.8236 USD
BB Width88.00%
ATR (14)0.1532 USD
Vol Ratio (20d)0.59x